Subscribe to RSS
DOI: 10.1055/s-0028-1083372
Synthesis of Glycoaminoxy Acids as Novel Sugar Building Blocks
Publication History
Publication Date:
11 February 2009 (online)
Abstract
Glycoaminoxy acids, a new class of sugar building blocks bearing both aminoxy and carboxylic acid functional groups on the sugar ring, have been efficiently synthesized from α-C-allyl glycosides. These compounds can be easily used for the synthesis of an N-oxy-amide-linked disaccharide and glycosyl amino acid mimetics.
Key words
glycoaminoxy acids - glycopeptides - glycomimetics - glycosides - oligosaccharides
The design and synthesis of new molecules with various functions has attracted much attention from organic, bioorganic, peptide, medicinal, as well as material chemistry. The creation of such cleverly functionalized molecules has a large impact in designing bioactive molecules and for drug discovery. Amino acids and carbohydrates are two fundamental chiral building blocks in Nature, generating diversity in biological systems. Recently, glycoamino acids or sugar amino acids, where amine and carboxylic acid functional groups were incorporated into the sugar ring, have been widely employed as carbohydrate scaffolds for preparing carbohydrate-based molecules with various applications. [¹] In the meanwhile, aminoxy acids, a class of unnatural amino acids where an aminoxy function has been introduced in place of the amine group, have emerged as very attractive scaffolds since the discovery of turns and helices structures in peptides containing aminoxy acids. [²] A new family of foldamers has been developed from α-, β-, and γ-aminoxy acids. [³] Oligomeric aminoxypeptides can also be prepared using solid phase techniques. [4] Thanks to the easy formation and stability of the oxime bond, aminoxy-functionalized peptides and proteins have been used as a tool in chemoselective ligation to prepare glycosylated pseudopeptides, [5] an anticancer vaccine, [6] or for high-throughput protein glycomics. [7] Through oxime ligation, peptide dendrimers, [8] protein-polymer conjugates, [9] bifunctional chelating agents, [¹0] and an oxime-peptide library [¹¹] have also been synthesized.
Aminoxy-functionalized saccharides have been reported for glycoconjugate synthesis [¹²] or as monosaccharide templates for the synthesis of ‘carboproteins’. [¹³] However, to the best of our knowledge, glycoaminoxy acids or sugar aminoxy acids having both aminoxy and carboxy functional groups incorporated into the sugar frameworks have not previously been reported (Figure 1). As a ‘sister’ of glycoamino acid, glycoaminoxy acid should represent a new class of multifunctional synthetic building blocks because both aminoxy and carboxylic acid functional groups can be readily used for further derivatization. In this paper, we report the synthesis of a glycoaminoxy acid and its derivatization.

Figure 1 Structure of glycoamino acids and glycoaminoxy acids
Aminoxy and carboxylic acid functions might be introduced into the different positions of furanosyl or pyranosyl sugar rings. Continuing our efforts in the synthesis and application of C-glycosyl building blocks, [¹4] we decided to prepare the first glucopyranosyl aminoxy acid from the known C-allyl glucoside 1 [¹4a] (Scheme 1). The Mitsunobu reaction of 1 with N-hydroxyphthalimide led to the protected aminoxy C-allyl glucoside 2 in 73% yield. The allyl group was then oxidized to a carboxylic acid by the combination of osmium tetroxide and Jones reagent; [¹4a] the protected glycoaminoxy acid 3 was obtained in 60% yield. The carboxylic acid function was then protected as the tert-butyl ester to give 4 (t-BuOH, DCC, DMAP). Cleavage of the phthalimido group was realized with hydrazine hydrate; the desired aminoxy ester 5 was obtained in 77% yield.

Scheme 1 Reagents and conditions: (a) PhthNOH, Ph3P, DIAD, toluene, 73%; (b) OsO4, Jones reagent, 60%; (c) t-BuOH, DCC, DMAP, CH2Cl2, 64%; (d) H2NNH2˙H2O, MeOH, 77%.
The synthesized glycoaminoxy acid derivatives were then tested as building blocks to generate oligosaccharide and glycopeptide mimetics. Coupling of the N-phthalimidoglycoaminoxy acid 3 with the glycoaminoxy ester 5 furnished the first N-oxy-amide-linked disaccharide 6 in 71% yield (Scheme 2). The coupling reagent diethyl cyanophosphonate (DEPC), which we have previously used to prepare oligomers of glycoamino acids, [¹4c] [d] proven to be efficient in this coupling. Reaction of the glycoaminoxy ester 5 with Boc-Gly-OH in the presence of diethyl cyanophosphonate/triethylamine led to the glycosylated amino acid 7 in 92% yield.

Scheme 2 Reagents and conditions: (a) DEPC, Et3N, THF.
In summary, from readily available C-allyl glycoside 1, we have succeeded in the synthesis of first C-glycoaminoxy acids, which can be readily converted into oligosaccharide or glycopeptide mimetics. These novel multifunctional sugar derivatives should find wide applications for chemoselective ligation of carbohydrate and peptides/proteins or as building blocks for the synthesis of various glycoconjugates.
All air-sensitive reactions were carried out under N2. Column chromatography was performed on E. Merck Silica Gel 60 (230-400 mesh). Petroleum ether = PE. Analytical TLC was performed on E. Merck aluminum pre-coated plates of Silica Gel 60F-254 with detection by UV and by spraying with 3 M H2SO4 and heating at 300 ˚C for ˜2 min. NMR spectra were recorded at r.t. with Jeol DX 400 spectrometers in CDCl3. HRMS spectra were measured by the Service de Spectrométrie de Masse de l’Université Pierre et Marie Curie-Paris 6.
3-(2,3,4-Tri- O -benzyl-6- O -phthalimido-α- d -glucopyranosyl)propene (2)
To a soln of 3-(2,3,4-tri-O-benzyl-α-d-glucopyranosyl)propene (1, 2 g, 4.2 mmol) in toluene (6 mL) was added successively at r.t. under N2, Ph3P (1.7 g, 6.72 mmol), PhthNOH (822 mg, 5.04 mmol). After cooling to 0 ˚C, DIAD (1.24 mL, 6.30 mmol) was then added. The mixture was stirred for 24 h, H2O-CH2Cl2 (2:3) was added, and the aqueous phase was extracted with CH2Cl2 (20 mL). The combined organic phases were washed with brine, dried (Na2SO4), filtered, and evaporated. Flash chromatography (EtOAc-PE, 1:9) gave 2 as a colorless oil; yield: 1.9 g (73%).
¹H NMR (400 MHz, CDCl3): δ = 2.45-2.47 (m, 2 H, H3), 3.72-3.74 (m, 2 H), 3.81 (t, J = 7.8 Hz, 1 H), 3.90 (dd, J = 8.2, 9.6 Hz, 1 H), 4.05-4.07 (m, 1 H, H1′), 4.35 (dd, J = 1.8, 10.6 Hz, 1 H, H6′), 4.41 (dd, J = 3.2, 10.6 Hz, 1 H, H6′′), 4.59 (d, J = 11.5 Hz, 1 H, OCH2Ph), 4.68 (d, J = 11.5 Hz, 1 H, OCH2Ph), 4.82 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.91 (d, J = 11.5 Hz, 1 H, OCH2Ph), 4.93 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.99 (d, J = 11.5 Hz, 1 H, OCH2Ph), 5.00-5.09 (m, 2 H, H2), 5.72-5.80 (m, 1 H, H1), 7.27-7.30 (m, 15 H, Ph), 7.72-7.80 (m, 4 H, Phth).
¹³C NMR (100 MHz, CDCl3): δ = 30.0 (C3), 70.1, 70.8 (CH), 73.1 (CH2), 73.8 (CH), 75.0, 75.2, 76.5 (CH2), 77.2, 79.5, 82.1 (CH), 116.8 (C1), 123.5 (Phth), 127.6, 127.8, 127.9, 128.1, 128.4, 128.5, 128.6, 128.9, 129.0, 129.3, 129.9 (Ph), 134.4 (Phth), 135.8 (C2), 138.2, 138.3, 138.7 (Cipso), 163.2 (C=O).
HRMS (ESI): m/z [M + H]+ calcd for C38H38NO7: 620.2648; found: 620.2641.
2-(2,3,4-Tri- O -benzyl-6- O -phthalimido-α- d -glucopyranosyl)ethanoic Acid (3)
OsO4 (4%) in t-BuOH(1.08 mL) and Jones reagent (4.8 mL) were added to a magnetically stirred soln of 2 (2.55 g, 4.1 mmol) in anhyd acetone (22 mL). The soln was stirred for 24 h and then a mixture of H2O-EtOAc (1:1) was added. The organic phase was washed with brine, dried (Na2SO4), filtered, and evaporated. Purification by flash chromatography (EtOAc-PE, 2:8 to 1:1) afforded 3 as a colorless oil; yield: 1.6 g (60%).
¹H NMR (400 MHz, CDCl3): δ = 2.75-2.78 (m, 2 H, H2), 3.75-3.89 (m, 4 H), 4.37 (m, 2 H, H6′), 4.59-4.65 (m, 3 H, H1′, OCH2Ph), 4.79 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.81 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.90 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.91 (d, J = 11.0 Hz, 1 H, OCH2Ph), 7.27-7.30 (m, 15 H, Ph), 7.72-7.80 (m, 4 H, Phth).
¹³C NMR (100 MHz, CDCl3): δ = 32.2 (C1), 71.1 (C1′), 72.1 (CH), 73.4, 75.1, 75.3, 76.6 (CH2), 76.8, 78.6, 81.6 (CH), 123.6 (Phth), 127.8, 127.9, 128.2, 128.5, 128.6, 129.0 (Ph), 134.5 (Phth), 137.8, 138.1, 138.5 (Cipso), 164.4, 175.6 (C=O).
HRMS (ESI): m/z [M + H]+ calcd for C37H36NO9: 638.2390; found: 638.2415.
tert -Butyl 2-(2,3,4-Tri- O -benzyl-6- O -phthalimido-α- d -glucopyranosyl)ethanoate (4)
t-BuOH (260 µL, 2.719 mmol) and DMAP (66 mg, 0.54 mmol) were successively added to a magnetically stirred soln of 3 (856 mg, 1.34 mmol) in anhyd CH2Cl2 (8 mL). The mixture was stirred and cooled to 0 ˚C and DCC (361 mg, 1.750 mmol) was added. After 6 h, a mixture of H2O-CH2Cl2 (2:3) was added and the organic phase was washed with brine, dried with (Na2SO4), and evaporated to dryness. Flash chromatography (EtOAc-PE, 2:8 to 3:7) gave 4 as a colorless oil; yield: 594 mg (64%).
¹H NMR (400 MHz, CDCl3): δ = 1.42 (s, 9 H, t-Bu), 2.62-2.64 (m, 2 H, H2), 3.71-3.82 (m, 3 H), 3.92 (dd, J = 8.7, 10.1 Hz, 1 H), 4.37 (dd, J = 2.3, 11.0 Hz, 1 H, H6′), 4.42 (dd, J = 3.7, 11.0 Hz, 1 H, H6′′), 4.55 (td, J = 5.5, 8.7 Hz, 1 H, H1′), 4.65 (s, 2 H, OCH2Ph), 4.82 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.90 (d, J = 11.0 Hz, 2 H, OCH2Ph), 4.95 (d, J = 11.0 Hz, 1 H, OCH2Ph), 7.30-7.32 (m, 15 H, Ph), 7.72-7.81 (m, 4 H, Phth).
¹³C NMR (100 MHz, CDCl3): δ = 28.1 (t-Bu), 33.7 (C1), 71.6 (CH), 71.8 (C1′), 73.3, 75.2, 75.4 (CH2), 76.1 (C6′), 77.3 (Cq), 78.9, 80.9, 81.2 (CH), 123.6 (Phth), 127.7, 127.9, 128.2, 128.5, 128.6, 129.0 (Ph), 134.5 (Phth), 137.8, 138.1, 138.5 (Cipso), 163.2, 170.5 (C=O).
HRMS (ESI): m/z [M + Na]+ calcd for C41H43NNaO9: 716.2938; found: 716.2830.
tert -Butyl 2-(6- O -Amino-2,3,4-tri- O -benzyl-α- d -glucopyranosyl)ethanoate (5)
A suspension of 4 (300 mg, 0.43 mmol) in MeOH (1.5 mL) was treated with H2NNH2˙H2O (64%, 65 µL). The resulting mixture was stirred at r.t. for 2 h. The progress of the reaction was monitored by TLC (EtOAc-PE, 3:7). The mixture was diluted with Et2O and was washed with sat. aq Na2CO3 soln. The aqueous layer was extracted with Et2O (3 ×). The combined organic layers were dried (Na2SO4), filtered, and evaporated. The residue was purified by flash chromatography (EtOAc-PE, 3:7) to afford 5 as a colorless oil; yield: 190 mg (77%).
¹H NMR (400 MHz, CDCl3): δ = 1.43 (s, 9 H, t-Bu), 2.62-2.64 (m, 2 H, H2), 3.46-3.49 (m, 1 H), 3.69-3.72 (m, 3 H), 3.82-3.83 (m, 2 H, H6′, H6′′), 4.53-4.56 (m, 1 H, H1′), 4.61 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.66 (s, 2 H, OCH2Ph), 4.80 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.84 (d, J = 11.0 Hz, 1 H, OCH2Ph), 4.90 (d, J = 11.0 Hz, 1 H, OCH2Ph), 7.28-7.30 (m, 15 H, Ph).
¹³C NMR (100 MHz, CDCl3): δ = 28.2 (t-Bu), 33.6 (C1), 71.4 (CH), 71.8 (C1′), 73.2 (CH2), 74.7 (C6′), 75.2, 75.6 (CH2), 78.1, 79.3 (CH), 80.9 (Cq), 82.3 (CH), 127.9, 128.5, 128.6 (Ph), 138.0, 138.2, 138.6 (Cipso), 170.6 (C=O).
HRMS (ESI): m/z [M + H]+ calcd for C33H42NO7: 564.2883; found: 564.2950.
tert -Butyl 2-(2,3,4-Tri- O -benzyl-6- O -{[(2,3,4-tri- O -benzyl-6- O -phthalimido-α- d -glucopyranosyl)carbonyl]amino}-α- d -glucopyranyl)ethanoate (6)
To a soln of 5 (190 mg, 0.35 mmol) in THF (4 mL), were added 3 (217 mg, 0.35 mmol), DEPC (79 µL, 0.35 mmol), and Et3N (145 µL, 1.05 mmol). The mixture was stirred overnight under N2 and then diluted with EtOAc-H2O (1:1) and separated. The aqueous layer was extracted with EtOAc. The combined organic layers were then washed with brine, dried (Na2SO4), filtered, concentrated, and purified by chromatography (EtOAc-PE, 3:7) to afford 6 as a colorless oil; yield: 291 mg (71%).
¹H NMR (400 MHz, CDCl3): δ = 1.40 (s, 9 H, t-Bu), 2.55 (m, 2 H, CH2), 2.63 (m, 2 H, CH2), 3.47 (t, J = 8.2 Hz, 1 H, H1), 3.67-3.77 (m, 4 H), 3.84-3.86 (m, 2 H, CH2), 3.99 (dd, J = 6.4, 11.9 Hz, 1 H), 4.09-4.19 (m, 2 H), 4.30 (dd, J = 4.6, 14.2 Hz, 1 H), 4.34-4.37 (m, 1 H), 4.46-4.53 (m, 1 H), 4.56-4.91 (m, 13 H), 7.26-7.28 (m, 30 H, Ph), 7.68-7.78 (m, 4 H, Phth), 9.61 (s, 1 H, NH).
¹³C NMR (100 MHz, CDCl3): δ = 28.2 (t-Bu), 30.8, 33.5 (C1), 71.2, 71.4, 71.5, 72.1 (CH), 72.9, 73.2, 74.8, 75.10, 75.14, 75.4 (CH2), 76.8 (CH), 77.2 (CH2), 78.0, 78.3, 79.2, 81.2 (CH), 81.4 (Cq), 81.9 (CH), 123.7 (Phth), 127.7, 127.9, 128.1, 128.2, 128.5, 128.9 (Ph), 134.5 (Phth), 138.0, 138.1, 138.5 (Cipso), 163.5, 167.8, 171.4 (C=O).
HRMS (ESI): m/z [M + Na]+ calcd for C70H74N2NaO15: 1205.5089; found: 1205.4981.
tert -Butyl 2-(2,3,4-Tri- O -benzyl-6- O -{[2-( tert -butoxycarbonylamino)acetyl]amino}-α- d -glucopyranosyl)ethanoate (7)
To a soln of 5 (203 mg, 0.36 mmol) in THF (5 mL) were added Boc-Gly-OH (63 mg, 0.35 mmol), DEPC (82 µL, 0.54 mmol), and Et3N (152 µL, 1.08 mmol). The mixture was stirred overnight under N2 and then diluted with EtOAc-H2O (1:1) and separated. The aqueous layer was extracted with EtOAc. The combined organic layers were then washed with brine, dried (Na2SO4), filtered, concentrated, and purified by chromatography (EtOAc-PE, 3:7) to afford 7 as a colorless oil; yield: 240 mg (92%).
¹H NMR (400 MHz, CDCl3): δ = 1.43 (s, 9 H, t-Bu), 1.44 (s, 9 H, t-Bu), 2.64-2.67 (m, 2 H, CH2), 3.33 (m, 1 H), 3.67-3.88 (m, 6 H), 4.10 (m, 1 H), 4.44 (m, 1 H), 4.62-4.90 (m, 6 H), 5.18 (s, 1 H, NH), 7.24-7.30 (m, 15 H, Ph), 9.66 (s, 1 H, NH).
¹³C NMR (100 MHz, CDCl3): δ = 28.2, 28.4 (t-Bu), 33.5, 42.1 (CH2), 70.9, 71.6 (CH), 73.4, 75.2, 75.5, 75.8 (CH2), 78.0, 79.1 (CH), 81.8 (Cq), 81.9 (CH), 128.0, 128.7 (Ph), 137.6, 137.8, 138.3 (Cipso), 155.9, 166.4, 171.7 (C=O).
HRMS (ESI): m/z [M + Na]+ calcd for C40H52N2NaO10: 743.3622; found: 743.3514.
- For reviews of sugar amino acids, see:
- 1a
Schweizer F. Angew. Chem. Int. Ed. 2002, 41: 231 - 1b
Gervay-Hague J.Weathers TM. J. Carbohydr. Chem. 2002, 7-9: 867 - 1c
Gruner SAW.Locardi E.Lohof E.Kessler H. Chem. Rev. 2002, 102: 491 - 1d
Chakraborty TK.Ghosh S.Jayaprakash S. Curr. Med. Chem. 2002, 9: 421 - 1e
Chakraborty TK.Srinivasu P.Tapadar S.Mohan BK. J. Chem. Sci. 2004, 116: 187 - 2a
Yang D.Ng F.-F.Li Z.-J.Wu Y.-D.Chan KWK.Wang D.-P. J. Am. Chem. Soc. 1996, 118: 9794 - 2b
Yang D.Qu J.Li B.Ng F.-F.Wang X.-C.Cheung K.-K.Wang D.-P.Wu Y.-D. J. Am. Chem. Soc. 1999, 121: 589 - 2c
Shin I.Lee M.Lee J.Jung M.Lee W.Yoon J. J. Org. Chem. 2000, 65: 7667 - 2d
Yang D.Li B.Ng F.-F.Yan Y.-L.Qu J.Wu Y.-D. J. Org. Chem. 2001, 66: 7303 - 2e
Chen F.Song K.-S.Wu Y.-D.Yang D. J. Am. Chem. Soc. 2008, 130: 743 - 2f
Li X.Wu Y.-D.Yang D. Acc. Chem. Res. 2008, 41: 1428 - 3a
Li X.Yang D. Chem. Commun. 2006, 3367 - 3b
Yang D.Zhang D.-W.Hao Y.Wu Y.-D.Luo S.-W.Zhu N.-Y. Angew. Chem. Int. Ed. 2004, 43: 6719 - 4
Lee M.Lee J.Baek B.Shin I. Synlett 2003, 325 - 5a
Shin I.Lee J. Synlett 2000, 1297 - 5b
Lee M.Lee J.Shin I. Synlett 2002, 1463 - 6a
Peri F.Cipolla L.Rescigno M.La Ferla B.Nicotra F. Bioconjugate Chem. 2001, 12: 325 - 6b
Cipolla L.Rescigno M.Leone A.Peri F.La Ferla B.Nicotra F. Bioorg. Med. Chem. 2002, 10: 1639 - 7
Niikura K.Kamitani R.Kurogochi M.Uematsu R.Shinohara Y.Nakagawa H.Deguchi K.Monde K.Kondo H.Nishimura S.-I. Chem. Eur. J. 2005, 11: 3825 - 8
Shao J.Tam JP. J. Am. Chem. Soc. 1995, 117: 3893 - 9
Esser-Kahn AP.Francis MB. Angew. Chem. Int. Ed. 2008, 47: 3751 - 10
Knör S.Modlinger A.Poethko T.Schottelius M.Wester H.-J.Kessler H. Chem. Eur. J. 2007, 13: 6082 - 11a
Liu F.Stephen AG.Fisher RJ.Burke TR. Bioorg. Med. Chem. Lett. 2008, 18: 1096 - 11b
Liu F.Stephen AG.Waheed AA.Aman MJ.Freed EO.Fisher RJ.Burke TR. ChemBioChem 2008, 9: 2000 - 12a
Rodriguez EC.Marcaurelle LA.Bertozzi CR. J. Org. Chem. 1998, 63: 7134 - 12b
Duléry V.Renaudet O.Philouze C.Dumy P. Carbohydr. Res. 2007, 342: 894 - 13a
Brask J.Jensen KJ. J. Pept. Sci. 2000, 6: 290 - 13b
Brask J.Jensen KJ. Bioorg. Med. Chem. Lett. 2001, 11: 697 - 13c
Tofteng AP.Hansen TH.Brask J.Nielsen J.Thulstrup PW.Jensen KJ. Org. Biomol. Chem. 2007, 5: 2225 - 13d
Jiménez-Castells C.de la Torre BG.Gutiérrez Gallego R.Andreu D. Bioorg. Med. Chem. Lett. 2007, 17: 5155 - 14a
Xie J. Eur. J. Org. Chem. 2002, 3411 - 14b
Xie J. Carbohydr. Res. 2003, 338: 399 - 14c
Durrat F.Xie J.Valéry JM. Tetrahedron Lett. 2004, 45: 1477 - 14d
Ménand M.Blais J.-C.Hamon L.Valéry J.-M.Xie J. J. Org. Chem. 2005, 70: 4423 - 14e
Ménand M.Blais J.-C.Valéry J.-M.Xie J. J. Org. Chem. 2006, 71: 3295
References
- For reviews of sugar amino acids, see:
- 1a
Schweizer F. Angew. Chem. Int. Ed. 2002, 41: 231 - 1b
Gervay-Hague J.Weathers TM. J. Carbohydr. Chem. 2002, 7-9: 867 - 1c
Gruner SAW.Locardi E.Lohof E.Kessler H. Chem. Rev. 2002, 102: 491 - 1d
Chakraborty TK.Ghosh S.Jayaprakash S. Curr. Med. Chem. 2002, 9: 421 - 1e
Chakraborty TK.Srinivasu P.Tapadar S.Mohan BK. J. Chem. Sci. 2004, 116: 187 - 2a
Yang D.Ng F.-F.Li Z.-J.Wu Y.-D.Chan KWK.Wang D.-P. J. Am. Chem. Soc. 1996, 118: 9794 - 2b
Yang D.Qu J.Li B.Ng F.-F.Wang X.-C.Cheung K.-K.Wang D.-P.Wu Y.-D. J. Am. Chem. Soc. 1999, 121: 589 - 2c
Shin I.Lee M.Lee J.Jung M.Lee W.Yoon J. J. Org. Chem. 2000, 65: 7667 - 2d
Yang D.Li B.Ng F.-F.Yan Y.-L.Qu J.Wu Y.-D. J. Org. Chem. 2001, 66: 7303 - 2e
Chen F.Song K.-S.Wu Y.-D.Yang D. J. Am. Chem. Soc. 2008, 130: 743 - 2f
Li X.Wu Y.-D.Yang D. Acc. Chem. Res. 2008, 41: 1428 - 3a
Li X.Yang D. Chem. Commun. 2006, 3367 - 3b
Yang D.Zhang D.-W.Hao Y.Wu Y.-D.Luo S.-W.Zhu N.-Y. Angew. Chem. Int. Ed. 2004, 43: 6719 - 4
Lee M.Lee J.Baek B.Shin I. Synlett 2003, 325 - 5a
Shin I.Lee J. Synlett 2000, 1297 - 5b
Lee M.Lee J.Shin I. Synlett 2002, 1463 - 6a
Peri F.Cipolla L.Rescigno M.La Ferla B.Nicotra F. Bioconjugate Chem. 2001, 12: 325 - 6b
Cipolla L.Rescigno M.Leone A.Peri F.La Ferla B.Nicotra F. Bioorg. Med. Chem. 2002, 10: 1639 - 7
Niikura K.Kamitani R.Kurogochi M.Uematsu R.Shinohara Y.Nakagawa H.Deguchi K.Monde K.Kondo H.Nishimura S.-I. Chem. Eur. J. 2005, 11: 3825 - 8
Shao J.Tam JP. J. Am. Chem. Soc. 1995, 117: 3893 - 9
Esser-Kahn AP.Francis MB. Angew. Chem. Int. Ed. 2008, 47: 3751 - 10
Knör S.Modlinger A.Poethko T.Schottelius M.Wester H.-J.Kessler H. Chem. Eur. J. 2007, 13: 6082 - 11a
Liu F.Stephen AG.Fisher RJ.Burke TR. Bioorg. Med. Chem. Lett. 2008, 18: 1096 - 11b
Liu F.Stephen AG.Waheed AA.Aman MJ.Freed EO.Fisher RJ.Burke TR. ChemBioChem 2008, 9: 2000 - 12a
Rodriguez EC.Marcaurelle LA.Bertozzi CR. J. Org. Chem. 1998, 63: 7134 - 12b
Duléry V.Renaudet O.Philouze C.Dumy P. Carbohydr. Res. 2007, 342: 894 - 13a
Brask J.Jensen KJ. J. Pept. Sci. 2000, 6: 290 - 13b
Brask J.Jensen KJ. Bioorg. Med. Chem. Lett. 2001, 11: 697 - 13c
Tofteng AP.Hansen TH.Brask J.Nielsen J.Thulstrup PW.Jensen KJ. Org. Biomol. Chem. 2007, 5: 2225 - 13d
Jiménez-Castells C.de la Torre BG.Gutiérrez Gallego R.Andreu D. Bioorg. Med. Chem. Lett. 2007, 17: 5155 - 14a
Xie J. Eur. J. Org. Chem. 2002, 3411 - 14b
Xie J. Carbohydr. Res. 2003, 338: 399 - 14c
Durrat F.Xie J.Valéry JM. Tetrahedron Lett. 2004, 45: 1477 - 14d
Ménand M.Blais J.-C.Hamon L.Valéry J.-M.Xie J. J. Org. Chem. 2005, 70: 4423 - 14e
Ménand M.Blais J.-C.Valéry J.-M.Xie J. J. Org. Chem. 2006, 71: 3295
References

Figure 1 Structure of glycoamino acids and glycoaminoxy acids

Scheme 1 Reagents and conditions: (a) PhthNOH, Ph3P, DIAD, toluene, 73%; (b) OsO4, Jones reagent, 60%; (c) t-BuOH, DCC, DMAP, CH2Cl2, 64%; (d) H2NNH2˙H2O, MeOH, 77%.

Scheme 2 Reagents and conditions: (a) DEPC, Et3N, THF.